2,6-diaminopurine has been researched along with Leukemia L 1210 in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (100.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
CUTTS, JH | 1 |
Cory, JG; Weckbecker, G | 1 |
2 other study(ies) available for 2,6-diaminopurine and Leukemia L 1210
Article | Year |
---|---|
EFFECTS OF OTHER AGENTS ON THE BIOLOGIC RESPONSES TO VINCALEUKOBLASTINE.
Topics: 2-Aminopurine; Aminopterin; Animals; Aspartic Acid; Azaguanine; Biological Products; Colchicine; Cortisone; Glutamates; Leukemia; Leukemia L1210; Leukemia, Experimental; Mercaptopurine; Methotrexate; Mice; Pharmacology; Purines; Research; Tryptophan; Vinblastine | 1964 |
2,6-Diaminopurinedeoxyriboside as a prodrug of deoxyguanosine in L1210 cells.
Topics: 2-Aminopurine; Adenosine Deaminase Inhibitors; Animals; Cell Division; Chromatography, High Pressure Liquid; Deoxyadenosines; Deoxycytidine; Deoxyguanosine; DNA Replication; Dose-Response Relationship, Drug; Leukemia L1210; Ribonucleotide Reductases | 1987 |